Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Computational Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nat Commun. 2020 Apr 24;11(1):2026. doi: 10.1038/s41467-020-15814-8.
The cell-context dependency for RNA binding proteins (RBPs) mediated control of stem cell fate remains to be defined. Here we adapt the HyperTRIBE method using an RBP fused to a Drosophila RNA editing enzyme (ADAR) to globally map the mRNA targets of the RBP MSI2 in mammalian adult normal and malignant stem cells. We reveal a unique MUSASHI-2 (MSI2) mRNA binding network in hematopoietic stem cells that changes during transition to multipotent progenitors. Additionally, we discover a significant increase in RNA binding activity of MSI2 in leukemic stem cells compared with normal hematopoietic stem and progenitor cells, resulting in selective regulation of MSI2's oncogenic targets. This provides a basis for MSI2 increased dependency in leukemia cells compared to normal cells. Moreover, our study provides a way to measure RBP function in rare cells and suggests that RBPs can achieve differential binding activity during cell state transition independent of gene expression.
RNA 结合蛋白 (RBP) 介导的干细胞命运调控的细胞上下文依赖性尚待确定。在这里,我们使用融合了果蝇 RNA 编辑酶 (ADAR) 的 RBP 来适应 HyperTRIBE 方法,以全局绘制哺乳动物成体正常和恶性干细胞中 RBP MSI2 的 mRNA 靶标。我们揭示了造血干细胞中独特的 MUSASHI-2 (MSI2) mRNA 结合网络,该网络在向多能祖细胞过渡时发生变化。此外,我们发现与正常造血干细胞和祖细胞相比,白血病干细胞中 MSI2 的 RNA 结合活性显著增加,导致 MSI2 的致癌靶标选择性调节。这为白血病细胞中 MSI2 依赖性增加相对于正常细胞提供了基础。此外,我们的研究为在稀有细胞中测量 RBP 功能提供了一种方法,并表明 RBPs 可以在不依赖基因表达的情况下在细胞状态转换过程中实现差异结合活性。